- Home
- XNCR vs ZUO Comparison
XNCR vs ZUO Comparison
Compare XNCR & ZUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- ZUO
- Stock Information
- Founded
- XNCR 1997
- ZUO 2006
- Country
- XNCR United States
- ZUO United States
- Employees
- XNCR N/A
- ZUO N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- ZUO EDP Services
- Sector
- XNCR Health Care
- ZUO Technology
- Exchange
- XNCR Nasdaq
- ZUO Nasdaq
- Market Cap
- XNCR 1.7B
- ZUO 1.5B
- IPO Year
- XNCR 2013
- ZUO 2018
- Fundamental
- Price
- XNCR $20.45
- ZUO $9.98
- Analyst Decision
- XNCR Strong Buy
- ZUO Buy
- Analyst Count
- XNCR 9
- ZUO 7
- Target Price
- XNCR $36.33
- ZUO $11.43
- AVG Volume (30 Days)
- XNCR 766.2K
- ZUO 2.1M
- Earning Date
- XNCR 02-25-2025
- ZUO 02-26-2025
- Dividend Yield
- XNCR N/A
- ZUO N/A
- EPS Growth
- XNCR N/A
- ZUO N/A
- EPS
- XNCR N/A
- ZUO N/A
- Revenue
- XNCR $85,164,000.00
- ZUO $452,763,000.00
- Revenue This Year
- XNCR N/A
- ZUO $7.42
- Revenue Next Year
- XNCR $80.86
- ZUO $7.04
- P/E Ratio
- XNCR N/A
- ZUO N/A
- Revenue Growth
- XNCR N/A
- ZUO 6.78
- 52 Week Low
- XNCR $15.31
- ZUO $7.70
- 52 Week High
- XNCR $27.24
- ZUO $10.85
- Technical
- Relative Strength Index (RSI)
- XNCR 38.80
- ZUO 65.23
- Support Level
- XNCR $19.15
- ZUO $9.89
- Resistance Level
- XNCR $24.66
- ZUO $9.98
- Average True Range (ATR)
- XNCR 1.14
- ZUO 0.02
- MACD
- XNCR -0.37
- ZUO 0.00
- Stochastic Oscillator
- XNCR 24.96
- ZUO 100.00
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About ZUO Zuora Inc.
Zuora Inc provides cloud-based software on a subscription basis that enables companies in various industries to launch, manage, and transform into a subscription business. The firm offers a Zuora Central platform that acts as an intelligent subscription management hub that automates the subscription order-to-cash process, including quoting, billing, collections, analytics, and revenue recognition. Its products include Zuora Billing, Zuora Revenue, Zuora Payments, Zephr, Zuora Platform, and other software that support and expand upon the core offerings. Geographically, it derives a majority of its revenue from the United States.